A Phase II, Single-Stage, Single Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection

Grant

Date/time Interval

  • July 1, 2016 - June 30, 2021
  • Total Award Amount

  • 3716696.00
  • Direct Costs

  • 3145076.00
  • Sponsor Award Id

  • HHSN272201600017C
  • Contributor

  • David Kimberlin M.D.   Principal Investigator  
  • Edward Acosta Pharm.D.   Investigator  
  • Inmaculada Aban   Investigator  
  • Karen Fowler   Investigator  
  • Richard Whitley M.D.   Investigator  
  • Scott James   Investigator  
  • Suresh Boppana M.D.   Investigator